wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
   Journals
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Archive
     Editorial staff
     Editorial board
     For authors
     Subscription
Otorhinolaryngology
Allergology Review



 Search in articles:
  Authority of Polish Society of Allergology




vol 11. no 3. September 2006  
 TABLE OF CONTENT

 Original articles
Pulmonary function in patients with arterial hypertension, bronchial asthma and chronic obstructive pulmonary disease after administration of selective β1-adrenoreceptor antagonists
Monika Ścibor, Grażyna Czerniawska-Mysik, Teresa Adamek-Guzik

Introduction. In the patients with arterial hypertension and concomitant bronchial asthma or chronic obstructive pulmonary disease (COPD), treatment intended to reduce blood pressure should be selected so as to ensure that the pulmonary function is not adversely affected.
Aim of the study. Evaluate the effect of a single dose of metoprolol (50mg) and bisoprolol (5mg) on pulmonary function.
Material and methods. The study was performed in the group of 50 (25 female and 25 male) patients with asthma or COPD and concomitant arterial hypertension. The mean age was 58.38±1.90 years. The influence of the tested drugs on pulmonary function was monitored in terms of the changes of spirometric parameters: FEV1, VC, FVC(EX), FEV1%VC, MEF25, MEF50, MEF75, and peak expiratory flow rate (PEFR), measured by a Wright meter. These tests were performed before administration of the study drugs and after 1 h, 2 hrs, 3 hrs and additionally after 4 hrs in the case of bisoprolol. At the same time points, patient's blood pressure was measured, while PEFR was additionally assessed after 12h.
The control group - 20 hypertensive patients without airway obstruction.
Results. The administration of study drugs caused a statistically significant deterioration in all analysed parameters. The changes of PEFR values after the administration of both drugs were statistically significant (p<0.001) and deteriorated gradually, reaching the poorest values after 2 and 3 hrs for metoprolol and bisoprolol, respectively.
Conclusions. Our results show that selective beta-1-adrenoreceptor antagonist drugs should be used with great care during hypotensive treatment of patients with bronchial asthma or chronic obstructive pulmonary disease.


keywords: metoprolol, bisoprolol, badania spirometryczne, metoprolol, bisoprolol, lung function test

pages: from 143 to 149



estimated time of download (129 kB)
broadband speed:561282565121024[kbps]
time:279532[sec]


You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.


Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.